BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 6323223)

  • 1. CI-906 and CI-907: new orally active nonsulfhydryl angiotensin-converting enzyme inhibitors.
    Kaplan HR; Cohen DM; Essenburg AD; Major TC; Mertz TE; Ryan MJ
    Fed Proc; 1984 Apr; 43(5):1326-9. PubMed ID: 6323223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antihypertensive effects of CI-907 (indolapril): a novel nonsulfhydryl angiotensin converting enzyme inhibitor.
    Ryan MJ; Boucher DM; Cohen DM; Essenburg AD; Major TC; Mertz TE; Olszewski BJ; Randolph AE; Singer RM; Kaplan HR
    J Pharmacol Exp Ther; 1984 Feb; 228(2):312-8. PubMed ID: 6319675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antihypertensive profile of the angiotensin-converting enzyme inhibitors CI-906 and CI-907.
    Ryan MJ; Boucher DM; Cohen DM; Olszewski BJ; Singer RM; Smith RD; Kaplan HR
    Fed Proc; 1984 Apr; 43(5):1330-2. PubMed ID: 6323224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of N-[(S)-1-carboxy-3-phenylpropyl]-L-Ala-L-Pro and its ethyl ester (MK-421) on angiotensin converting enzyme in vitro and angiotensin I pressor responses in vivo.
    Gross DM; Sweet CS; Ulm EH; Backlund EP; Morris AA; Weitz D; Bohn DL; Wenger HC; Vassil TC; Stone CA
    J Pharmacol Exp Ther; 1981 Mar; 216(3):552-7. PubMed ID: 6259322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antihypertensive properties of a new long-acting angiotensin converting enzyme inhibitor in renin-dependent and independent hypertensive models.
    Nagata S; Takeyama K; Fukuya F; Nagai R; Hosoki K; Nishimura K; Deguchi T; Karasawa T
    Arzneimittelforschung; 1995 Aug; 45(8):853-8. PubMed ID: 7575746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological and toxicological studies of the new angiotensin converting enzyme inhibitor moexipril hydrochloride.
    Friehe H; Ney P
    Arzneimittelforschung; 1997 Feb; 47(2):132-44. PubMed ID: 9079232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Possible involvement of ATP-dependent K-channel related mechanisms in the antihypertensive and cough suppressant effects of the novel ACE inhibitor (2S, 3aS, 7aS)-1-(N2-nicotinoyl-L-lysyl-gamma-D-glutamyl)octahydro-1H- indole-2-carboxylic acid.
    Nagata S; Takeyama K; Hosoki K; Karasawa T
    Arzneimittelforschung; 1997 Jun; 47(6):726-30. PubMed ID: 9239450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of two structurally different angiotensin-converting enzyme inhibitors, captopril and quinapril (CI-906), in rats with one-kidney deoxycorticosterone-salt hypertension.
    Pörsti I; Säynävälammi P; Arvola P; Nurmi AK; Manninen V; Ylitalo P; Vapaatalo H
    Methods Find Exp Clin Pharmacol; 1986 Sep; 8(9):543-6. PubMed ID: 3022083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin-converting enzyme inhibition with quinapril (CI-906) and captopril in spontaneously hypertensive rats with suppressed renin-angiotensin system.
    Säynävälammi P; Pörsti I
    Methods Find Exp Clin Pharmacol; 1987 Jun; 9(6):325-31. PubMed ID: 3309510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacology of idrapril: a new class of angiotensin converting enzyme inhibitors.
    Subissi A; Criscuoli M; Sardelli G; Guelfi M; Giachetti A
    J Cardiovasc Pharmacol; 1992 Jul; 20(1):139-46. PubMed ID: 1383623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of angiotensin I-converting enzyme with S 9490: biochemical effects, interspecies differences, and role of sodium diet in hemodynamic effects.
    Laubie M; Schiavi P; Vincent M; Schmitt H
    J Cardiovasc Pharmacol; 1984; 6(6):1076-82. PubMed ID: 6084763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological properties of the converting enzyme inhibitor, enalapril maleate (MK-421).
    Sweet CS
    Fed Proc; 1983 Feb; 42(2):167-70. PubMed ID: 6295819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin-converting enzyme inhibitory activity of SCH 31846, a new non-sulfhydryl inhibitor.
    Sybertz EJ; Baum T; Ahn HS; Nelson S; Eynon E; Desiderio DM; Pula K; Becker F; Sabin C; Moran R; Vander Vliet G; Kastner B; Smith E
    J Cardiovasc Pharmacol; 1983; 5(4):643-54. PubMed ID: 6193364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Moexipril, a new angiotensin-converting enzyme (ACE) inhibitor: pharmacological characterization and comparison with enalapril.
    Edling O; Bao G; Feelisch M; Unger T; Gohlke P
    J Pharmacol Exp Ther; 1995 Nov; 275(2):854-63. PubMed ID: 7473177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological properties of the new non-sulfhydryl angiotensin converting enzyme inhibitor N-[8-amino-1(S)-carboxyoctyl]-L-alanyl-L-proline.
    Shirota M; Kajiwara Y; Iijima M; Kitabatake K
    Arzneimittelforschung; 1990 May; 40(5):515-9. PubMed ID: 2166521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of captopril and enalapril on sodium excretion and blood pressure in sodium-deficient dogs.
    McCaa RE; Gillespie JB
    Fed Proc; 1984 Apr; 43(5):1336-41. PubMed ID: 6323226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do the cardiovascular effects of angiotensin-converting enzyme (ACE) I involve ACE-independent mechanisms? new insights from proline-rich peptides of Bothrops jararaca.
    Ianzer D; Santos RA; Etelvino GM; Xavier CH; de Almeida Santos J; Mendes EP; Machado LT; Prezoto BC; Dive V; de Camargo AC
    J Pharmacol Exp Ther; 2007 Aug; 322(2):795-805. PubMed ID: 17475904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of angiotensin converting enzyme (ACE) in plasma and tissues: studies ex vivo after administration of ACE inhibitors.
    Johnston CI; Mendelsohn FA; Cubela RB; Jackson B; Kohzuki M; Fabris B
    J Hypertens Suppl; 1988 Dec; 6(3):S17-22. PubMed ID: 2852234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differing effects of two angiotensin converting enzyme inhibitors, captopril and CI-906, on diuresis and the urinary excretion of kallikrein and prostaglandins in spontaneously hypertensive rats.
    Säynävälammi P; Pörsti I; Nurmi AK; Seppälä E; Laitinen LA; Manninen V; Ylitalo P; Vapaatalo H
    Scand J Urol Nephrol Suppl; 1984; 79():23-7. PubMed ID: 6089314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the new angiotensin-I-converting enzyme inhibitor imidapril on the responses of isolated vascular preparations to various agonists.
    Kubo M; Fujitsuka T; Ishida R
    Arzneimittelforschung; 1992 Apr; 42(4):446-51. PubMed ID: 1642667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.